A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer
Clinical trial NCT07135544 · RECRUITING
Trial details
- NCT number
- NCT07135544
- Sponsor
- Yongjun Chen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-14
- Primary completion
- 2027-06-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.